Treatment of digestive carcinoid tumors;Tumeurs carcinoides digestives: Mise au point sur le traitement

Revue de Medecine Interne

Volumn 20, Issue 5, 1999, Pages 421-426

  Madeira, I ^a   Ruszniewski, P ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Carcinoid tumor; Chemotherapy; Hepatic arterial chemoembolization; Liver metastases; Somatostatine

Indexed keywords

ANGIOPEPTIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; OCTREOTIDE;

ARTIFICIAL EMBOLISM; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARCINOID; DIARRHEA; FLUSHING; HUMAN; INTESTINE CARCINOMA; LIVER METASTASIS; LIVER RESECTION; REVIEW; SURVIVAL TIME; TREATMENT OUTCOME; DIGESTIVE SYSTEM TUMOR; LIVER TUMOR; METASTASIS;

CARCINOID TUMOR; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; LIVER NEOPLASMS;

EID: 0032723311     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(99)83094-X     Document Type: Review

References (31)

1. Godwin DJ. Carcinoid tumors: an analysis of 2837 cases. Cancer. 36:1975;560-569.
2. Martensson H, Nobin A, Sundler F. carcinoid tumors in the gastrointestinal tract: an analysis of 156 cases. Acta Chir Scand. 149:1983;607-616.
3. Moertel CG, Weiland LH, Nagorney DM, Dockerty MB. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med. 317:1987;1699-1701.
4. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 79:1997;813-829.
5. Thompson GB, van Heerden JA, Martin JK, Schutt AJ, Ilstrup DM, Carney JA. Carcinoid tumors of the gastrointestinal tract: presentation, management and prognosis. Surgery. 98:1985;1054-1061.
6. Bowman GA, Rosenthal D. Carcinoid of the appendix. Am J Surg. 148:1983;700-703.
7. Moertel CG. An odyssey in the land of small tumors. J. Clin Oncol. 5:1987;1503-1522.
8. Syracuse DG, Perzin KU, Price JB, Wiedel PD, Mesatejada R. Carcinoid tumors of the appendix: meso appendiceal and nodal metastases. Am Surg. 190:1979;58-63.
9. Mani S, Modlin IM, Ballantyne G, Ahlman H, West B. Carcinoids of the rectum. J Am Coll Surg. 179:1994;231-248.
10. Stinner B, Kiker O, Zielke A, Rothmund M. Surgical management for carcinoid tumors of small bowel. Appendix, colon an rectum. World J Surg. 20:1996;183-188.
11. Votte A, Gattan D, Dupas JL. Traitement des tumeurs carcinoïdes du tube digestif. Gastroentérol Clin Biol. 19:1995;1031-1042.
12. Mc Entee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery. 108:1990;1091-1096.
13. Letreut YP, Delpero JP, Houssin D, Cherqui D, Segol P, Mantion G, et al. Que peut-on attendre de la transplantation hépatique pour métastases des tumeurs neuro-endocrine ? Résultats d'une étude multicentrique de 28 cas. Gastroentérol Clin Biol. 19:1995;A4.
14. Engstrom PF, Lavin PT, Moertel CG, Folsch E, Douglass HO. Streptozotocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol. 2:1984;1255-1259.
15. Moertel CG, Hanley JA. Combination therapy trials in metastatic carcinoid tumors and the malignant carcinoid syndrome. Cancer Clin Trials. 2:1979;327-334.
16. Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome: evaluation of a long acting somatostatin analogue. N Engl J Med. 315:1986;663-666.
17. Arnold R, Trautmann ME, Creutzfeld W, Benning R, Benning M, Neuhaus C, et al. Somatostatin analogues octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut. 38:1996;430-438.
18. Dirix LY, Prove A, Schrijvers GK, Fierens H, Van Oosteron AT. A long-term study of continuous treatment with alpha-interferon in patients with metastatic carcinoid tumors. Proc Am Soc Clin Oncol. 13:1994;190.
19. Ruszniewski P, Rougier P, Roche A, Legmann P, Sibert A, Hochlaf S, et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. Cancer. 71:1993;2624-2630.
20. Souquet JC, Sassolas G, Forichon J, Champetier P, Partensky C, Chayvialle JA. Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome. Cancer. 59:1987;1654-1660.
21. Jansson ET, Oberg K. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alfa-interferon. Acta Oncol. 32:1993;225-229.
22. Ruszniewski P, Ducreux M, Chayvialle JA, Blumberg J, Cloarec D, Michel H, et al. Treatment of the carcinoid syndrome with the long-acting somatostatin analogue lanreotide: a prospective study in 39 patients. Gut. 39:1996;279-283.
23. Marsh HM, Martin JK Jr, Kvols LK, Gracey DR, Warner ME, Moertell CG, et al. Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue. Anesthesiology. 66:1987;89-91.
24. Kvols LK, Moertel CG, O'Connell MJ, et al. Carcinoid crisis. Successful treatment and prevention with somatostatin analog (SMS 201-995). Proc Am Soc Clin Oncol. 6:1987;96-98.
25. Bukowski RM, Johnson KG, Peterson RF, Stephens RL, Rivkin SE, Neilan B, et al. A phase III trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest oncology Group Study. Cancer. 60:1987;2891-2895.
26. Kelsen DP, Cheng E, Kemeny N, Magill GB, Yagoda A. Streptozotocin and adriamycin in the treatment of APUF tumors (carcinoid, islet cell and medullary carcinoma of the thyroid). Proc Am Assoc Cancer Res. 23:1982;111.
27. Haller DG, Schutt A, Dayal Y, Ryan L, Liptsitz S. Chemotherapy for metastatic carcinoid tumors: an ECOG phase II-III trial. Proc Am Soc Clin Oncol. 9:1990;102.
28. Rougier P, Oliveira J, Ducreux M, Theodore C, Kac J, Droz JP. Metastatic carcinoid and islet cell tumors of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluoro-uracil, doxorubicin and cisplatin. Eur J Cancer. 27:1991;1380-1382.
29. Moertel CG, Kvols LK, O'Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Cancer. 68:1991;227-232.
30. Vynik R, Anderson JV, Williams SJ, Blooms R. Resistance of metastatic pancreatic endocrine tumors after long term treatment with the somatostatin analog octreotide (SMS 201-995). Clin Endocrinol. 30:1989;385-388.
31. Ruszniewski P, Ducreux M, Chayvialle JA, Blumberg J, Cloarec D, Michel H, et al. Treatment of the carcinoid syndrome with the long-acting somatostatin analogue lanreotide : a prospective study in 39 patients. Gut. 39:1996;279-283.